Updated Jul 16, 2026
Vazzano Joseph Walter has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $860K.

Joseph Walter Vazzano is the Chief Financial Officer of Abeona Therapeutics Inc, a clinical-stage biopharmaceutical company focused on developing gene therapies for rare genetic diseases. He has been involved in the company's financial operations and has filed multiple SEC reports related to his role.
| Role | Chief Financial Officer |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-09 | ABEO | ABEONA THERAPEUTICS INC. | S — Open-market sale | 24.9K | $6.96 | $173K |
| 2026-06-10 | ABEO | ABEONA THERAPEUTICS INC. | S — Open-market sale | 25.6K | $5.39 | $138K |
| 2026-06-10 | ABEO | ABEONA THERAPEUTICS INC. | S — Open-market sale | 13.4K | $5.30 | $71K |
| 2026-06-10 | ABEO | ABEONA THERAPEUTICS INC. | S — Open-market sale | 10.3K | $5.43 | $56K |
| 2026-03-16 | ABEO | ABEONA THERAPEUTICS INC. | S — Open-market sale | 785 | $4.76 | $4K |
| 2026-01-23 | ABEO | ABEONA THERAPEUTICS INC. | S — Open-market sale | 18.7K | $5.33 | $100K |
| 2026-01-20 | ABEO | ABEONA THERAPEUTICS INC. | A — Grant or award | 133.6K | $0.00 | |
| 2025-09-29 | ABEO | ABEONA THERAPEUTICS INC. | S — Open-market sale | 9.0K | $5.39 | $49K |
| 2025-08-15 | ABEO | ABEONA THERAPEUTICS INC. | S — Open-market sale | 15.0K | $7.36 | $110K |
| 2025-07-22 | ABEO | ABEONA THERAPEUTICS INC. | S — Open-market sale | 1.5K | $6.64 | $10K |
| 2025-07-09 | ABEO | ABEONA THERAPEUTICS INC. | S — Open-market sale | 25.4K | $5.86 | $149K |
Joseph Walter Vazzano is the Chief Financial Officer of Abeona Therapeutics Inc, a clinical-stage biopharmaceutical company focused on developing gene therapies for rare genetic diseases. He has been involved in the company's financial operations and has filed multiple SEC reports related to his role.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 10 open-market sales ($860K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Vazzano Joseph Walter profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.